通用中文 | 阿瑞吡坦胶囊 | 通用外文 | Aprepitant capsules |
品牌中文 | イメンドカプセル | 品牌外文 | EMEND |
其他名称 | アプレピタント | ||
公司 | 小野(Onokazu) | 产地 | 日本(Japan) |
含量 | 80mg | 包装 | 30粒/盒 |
剂型给药 | 储存 | 室温 | |
适用范围 | 肿瘤化疗所引致的恶心及呕吐 |
通用中文 | 阿瑞吡坦胶囊 |
通用外文 | Aprepitant capsules |
品牌中文 | イメンドカプセル |
品牌外文 | EMEND |
其他名称 | アプレピタント |
公司 | 小野(Onokazu) |
产地 | 日本(Japan) |
含量 | 80mg |
包装 | 30粒/盒 |
剂型给药 | |
储存 | 室温 |
适用范围 | 肿瘤化疗所引致的恶心及呕吐 |
英文药名:EMEND(Aprepitant capsules)
中文药名:阿瑞吡坦胶囊
生产厂家:小野薬品
治疗类别名称
选择性NK1受体拮抗剂止吐剂
通用名称:阿瑞匹坦胶囊
英文名称:Aprepitant Capsules
汉语拼音:Aruipitan Jiaonang
主要成分:阿瑞匹坦
适 应 症:化疗呕吐
用法用量
Emend为口服胶囊剂,临床上用于与其它止吐药联合用药。连续三天,每日一次剂量,推荐剂量为化疗前1小时,口服125mg,第二,三天清晨各80mg,无论与食物是否同服均可。
规 格
(1)阿瑞匹坦胶囊125毫克:3粒(PTP),6粒(PTP)
(2)阿瑞匹坦胶囊80毫克:6粒(PTP),30粒(PTP)
(3)阿瑞匹坦组合胶囊(125毫克胶囊×1,80mg胶囊×2)/张
包装
铝塑板包装。
贮藏
30℃以下原包装保存。
生产商
小野薬品工業株式会社
Emend (aprepitant) is a neurokinin-1 (NK1)-receptor antagonist. It stops a chemical in the body (substance P) from binding to the NK1 receptors. When substance P attaches to these receptors, it causes nausea and vomiting. By blocking the receptors, Emend can prevent nausea and vomiting, which often happens after chemotherapy or as a complication of surgery.
注:本品原处方附件:http://www.kegg.jp/medicus-bin/japic_med?japic_code=00058171
阿瑞匹坦产品特点
阿瑞吡坦(aprepitanl)及福沙吡坦(fosapitant)是目前上市用于止吐的NK.1受体拮抗剂。阿瑞吡坦的前体药物静脉用福沙吡坦二甲葡胺注射液。NK-1受体是速激肽(NKA)P物质(SP)的结合位点,位于脑干呕吐中枢和胃肠道。动物试验证明SP能诱发呕吐.而特异性阻断该受体的药物能预防所有致吐刺激物(包括顺铂)导致的呕吐。
多项临床研究证明,包含阿瑞吡坦的止吐方案在预防高、中致吐风险药物(尤其以顺铂为主的化疗药物)导致的急性和迟发性CINV时疗效更佳,而且不加重不良反应。阿瑞吡坦还是细胞色素P450(CYP)3A4的中度抑制剂。理论上由于某些止吐药(如糖皮质激素)和化疗药(如环磷酰胺和多西他赛)为CYP3A4的底物,当其与阿瑞吡坦联用时代谢会受到影响。因此,当联用糖皮质激素和阿瑞吡坦时前者的剂量应减低。但这并不适用于接受含糖皮质激素化疗方案者。目前临床上也未见标准用法及用量的阿瑞吡坦与上述化疗药合用导致临床后遗症的任何证据。新指南建议,目前只按已确定的阿瑞吡坦的剂量和方案用药。
对急性CINV的预防,接受高致吐风险药物化疗者以及接受蒽环类药物和环磷酰胺联合化疗的患者推荐5-HT3受体阻断剂、地塞米松和阿瑞吡坦(一次125mg)联用。对所有接受顺铂和其他高致吐风险药物化疗的患者,推荐应用地塞米松和阿瑞吡坦(一次80mg×2日)二联药物预防迟发性CINV,不再推荐5-HT。受体阻断剂和地塞米松二药联合。对于接受蒽环类药物和环磷酰胺联合化疗的患者,推荐应用阿瑞吡坦单药治疗。
作用と効果について
中枢性の嘔吐反応を抑制することで、吐き気や嘔吐を抑えます。
通常、抗悪性腫瘍剤による吐き気や嘔吐などの消化器症状の予防に用いられます。
次のような方は使う前に必ず担当の医師と薬剤師に伝えてください。
以前に薬を使用して、かゆみ、発疹などのアレルギー症状が出たことがある。
妊娠または授乳中
他に薬などを使っている(お互いに作用を強めたり、弱めたりする可能性もありますので、他に使用中の一般用医薬品や食品も含めて注意してください)。
用法・用量
通常、成人および12歳以上の小児には1日目125mgカプセル1カプセルを1日1回、2日目以降は80mgカプセル1カプセルを1日1回服用します。1日目は抗悪性腫瘍剤の投与開始1~1時間30分前に、2日目以降は午前中に服用してください。必ず指示された服用方法に従ってください。
飲み忘れた場合はすぐに医師または薬剤師に相談し、指示に従ってください。絶対に2回分を一度に飲んではいけません。
誤って多く飲んだ場合は医師または薬剤師に相談してください。
医師の指示なしに、自分の判断で飲むのを止めないでください。
副作用について
主な副作用として、しゃっくり、頭痛、便秘、下痢、食欲不振、悪心、無力症、発疹などが報告されています。このような症状に気づいたら、担当の医師または薬剤師に相談してください。
まれに下記のような症状があらわれ、[ ]内に示した副作用の初期症状である可能性があります。
このような場合には、使用をやめて、すぐに医師の診療を受けてください。
・発熱、紅斑、眼の充血 [皮膚粘膜眼症候群]
・激しい腹痛、嘔吐、下血 [穿孔性十二指腸潰瘍]
・全身発疹、潮紅、呼吸困難、血管浮腫、紅斑 [ショック、アナフィラキシー]
以上の副作用はすべてを記載したものではありません。上記以外でも気になる症状が出た場合は、医師または薬剤師に相談してください。
保管方法その他
乳幼児、小児の手の届かないところで、直射日光、高温、湿気を避けて保管してください。
薬が残った場合、保管しないで廃棄してください。
aprepitant
Generic Name: aprepitant (a PREP i tant)
Brand Name: Emend, Emend 2-Day, Emend 3-Day
What is aprepitant?
Aprepitant blocks the actions of chemicals in the body that trigger nausea and vomiting.
Aprepitant is used in adults and children to prevent nausea and vomiting caused by cancer chemotherapy. Aprepitant is also used (only in adults) to prevent nausea and vomiting that may be caused by surgery.
Aprepitant is given ahead of time and will not treat nausea or vomiting that you already have.
Aprepitant capsules are for use in adults and children who are at least 12 years old. Aprepitant oral suspension (liquid) can be given to adults and children as young as 6 months old.
Aprepitant may also be used for purposes not listed in this medication guide.
Important Information
You should not take aprepitant if you also take pimozide. A serious drug interaction can occur when pimozide is used together with aprepitant.
Before taking this medicine
You should not use aprepitant if you are allergic to it, or if you take another medicine called pimozide (Orap). Aprepitant can cause unwanted or dangerous effects when used with pimozide.
To make sure aprepitant is safe for you, tell your doctor if you have:
It is not known whether this medicine will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.
Aprepitant can make birth control pills less effective. Ask your doctor about using a non-hormonal birth control (condom, diaphragm with spermicide) to prevent pregnancy, and for 1 month after your last dose.
It is not known whether aprepitant passes into breast milk or if it could harm a nursing baby. Tell your doctor if you are breast-feeding a baby.
How should I take aprepitant?
Follow all directions on your prescription label. Do not take this medicine in larger or smaller amounts or for longer than recommended.
Aprepitant is not for long-term use. For use in chemotherapy, you will most likely need only 3 separate doses. When used before surgery, you will likely receive only 1 dose.
The first dose of aprepitant is usually taken 1 hour before treatment with chemotherapy, or 3 hours before a surgery. Follow your doctor's dosing instructions very carefully.
You may also be given other medicines with aprepitant to further help prevent nausea and vomiting.
Read all patient information, medication guides, and instruction sheets provided to you. Ask your doctor or pharmacist if you have any questions.
Aprepitant can be taken with or without food. If you take aprepitant before surgery, follow your doctor's instructions about any restrictions on food or beverages.
Do not crush, chew, break, or open an aprepitant capsule. Swallow it whole.
Give the oral suspension (liquid) using only the dosing syringe provided.
Do not share this medicine with another person. Aprepitant should not be used to treat general nausea that is unrelated to chemotherapy or surgery.
If you also take warfarin (Coumadin, Jantoven), you may need extra "INR" or prothrombin time tests after you have taken aprepitant.
Store aprepitant capsules at room temperature away from moisture and heat.
Store the prefilled liquid dosing syringe in the refrigerator, do not freeze. After taking the liquid out of the refrigerator, you must use it within 3 hours.
Throw away any liquid medicine not used within 3 days (72 hours) after you received it. Do not save it for later use.
What happens if I miss a dose?
Call your doctor for instructions if you forget to take your medicine within the prescribed length of time before your chemotherapy or surgery.
What happens if I overdose?
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.
What should I avoid while taking aprepitant?
Follow your doctor's instructions about any restrictions on food, beverages, or activity.
Aprepitant side effects
Get emergency medical help if you have signs of an allergic reaction: hives, rash, itching, skin sores or peeling; warmth or tingly feeling; trouble breathing or swallowing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
· a light-headed feeling, like you might pass out;
· low blood cell counts--fever, chills, flu-like symptoms, swollen gums, mouth sores, skin sores, rapid heart rate, pale skin, easy bruising, unusual bleeding; or
· dehydration symptoms--feeling very thirsty or hot, being unable to urinate, heavy sweating, or hot and dry skin.
Common side effects may include:
· stomach pain, indigestion, loss of appetite;
· diarrhea, constipation;
· hiccups;
· abnormal liver function tests;
· cough; or
· feeling weak or tired.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
See also: Side effects (in more detail)
Aprepitant dosing information
Usual Adult Dose for Nausea/Vomiting -- Chemotherapy Induced:
MODERATELY TO HIGHLY EMETOGENIC CANCER CHEMOTHERAPY (HEC/MEC):
Oral Capsules:
-Day 1: 125 mg orally once 1 hour before chemotherapy
-Days 2 and 3: 80 mg orally once a day, 1 hour before chemotherapy OR in the morning (if chemotherapy is not given on Days 2 and 3)
-Duration of therapy: 3 days/cycle
Oral Suspension:
-Day 1: 3 mg/kg orally once 1 hour before chemotherapy
---Maximum dose: 125 mg/dose
-Days 2 to 3: 2 mg/kg orally once a day, 1 hour before chemotherapy OR in the morning (if chemotherapy is not given on Days 2 and 3)
---Maximum dose: 80 mg/dose
-Duration of therapy: 3 days/cycle
Comments:
-The recommended dosage of dexamethasone is 12 mg orally on Day 1 administered 30 minutes prior to chemotherapy and 8 mg orally in the mornings on Days 2 through 4 (HEC) or Days 2 through 3 (MEC).
-The 5-HT3 antagonist is administered on Day 1 only. Consult the package insert for the 5-HT3 antagonist dosing prior to initiation of treatment.
-This drug may be taken with or without food.
Uses:
-In combination with other antiemetic agents for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of HEC including high-dose cisplatin
-In combination with other antiemetic agents for the prevention of nausea and vomiting associated with initial and repeat courses of MEC
Usual Adult Dose for Nausea/Vomiting -- Postoperative:
40 mg orally once within 3 hours prior to induction of anesthesia
Use: Prevention of nausea and vomiting
Usual Pediatric Dose for Nausea/Vomiting -- Chemotherapy Induced:
12 years and older:
MEC/HEC:
Oral Capsules:
-Day 1: 125 mg orally once 1 hour before chemotherapy
-Days 2 and 3: 80 mg orally once a day, 1 hour before chemotherapy OR in the morning (if chemotherapy is not given on Days 2 and 3)
-Duration of therapy: 3 days/cycle
Oral Suspension:
-Day 1: 3 mg/kg orally once 1 hour before chemotherapy
---Maximum dose: 125 mg/dose
-Days 2 to 3: 2 mg/kg orally once a day, 1 hour before chemotherapy OR in the morning (if chemotherapy is not given on Days 2 and 3)
---Maximum dose: 80 mg/dose
-Duration of therapy: 3 days/cycle
Comments:
-If a corticosteroid (e.g., dexamethasone) is coadministered, patients should be given 50% of the recommended pediatric dose on Days 1 to 4. Consult the package insert for the corticosteroid dosing prior to initiation of treatment.
-The 5-HT3 antagonist is administered on Day 1 only. Consult the package insert for the 5-HT3 antagonist dosing prior to initiation of treatment.
-This drug may be taken with or without food.
Uses:
-In combination with other antiemetic agents for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of HEC including high-dose cisplatin
-In combination with other antiemetic agents for the prevention of nausea and vomiting associated with initial and repeat courses of MEC
What other drugs will affect aprepitant?
Sometimes it is not safe to use certain medications at the same time. Some drugs can affect your blood levels of other drugs you take, which may increase side effects or make the medications less effective.
Many drugs can interact with aprepitant. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide. Tell your doctor about all your current medicines and any medicine you start or stop using.